Modeling psychological function in patients with schizophrenia with the PANSS: an international multi-center study.


Journal

CNS spectrums
ISSN: 1092-8529
Titre abrégé: CNS Spectr
Pays: United States
ID NLM: 9702877

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 16 4 2020
medline: 8 1 2022
entrez: 16 4 2020
Statut: ppublish

Résumé

The aim of the current study was to explore the changing interrelationships among clinical variables through the stages of schizophrenia in order to assemble a comprehensive and meaningful disease model. Twenty-nine centers from 25 countries participated and included 2358 patients aged 37.21 ± 11.87 years with schizophrenia. Multiple linear regression analysis and visual inspection of plots were performed. The results suggest that with progression stages, there are changing correlations among Positive and Negative Syndrome Scale factors at each stage and each factor correlates with all the others in that particular stage, in which this factor is dominant. This internal structure further supports the validity of an already proposed four stages model, with positive symptoms dominating the first stage, excitement/hostility the second, depression the third, and neurocognitive decline the last stage. The current study investigated the mental organization and functioning in patients with schizophrenia in relation to different stages of illness progression. It revealed two distinct "cores" of schizophrenia, the "Positive" and the "Negative," while neurocognitive decline escalates during the later stages. Future research should focus on the therapeutic implications of such a model. Stopping the progress of the illness could demand to stop the succession of stages. This could be achieved not only by both halting the triggering effect of positive and negative symptoms, but also by stopping the sensitization effect on the neural pathways responsible for the development of hostility, excitement, anxiety, and depression as well as the deleterious effect on neural networks responsible for neurocognition.

Sections du résumé

BACKGROUND
The aim of the current study was to explore the changing interrelationships among clinical variables through the stages of schizophrenia in order to assemble a comprehensive and meaningful disease model.
METHODS
Twenty-nine centers from 25 countries participated and included 2358 patients aged 37.21 ± 11.87 years with schizophrenia. Multiple linear regression analysis and visual inspection of plots were performed.
RESULTS
The results suggest that with progression stages, there are changing correlations among Positive and Negative Syndrome Scale factors at each stage and each factor correlates with all the others in that particular stage, in which this factor is dominant. This internal structure further supports the validity of an already proposed four stages model, with positive symptoms dominating the first stage, excitement/hostility the second, depression the third, and neurocognitive decline the last stage.
CONCLUSIONS
The current study investigated the mental organization and functioning in patients with schizophrenia in relation to different stages of illness progression. It revealed two distinct "cores" of schizophrenia, the "Positive" and the "Negative," while neurocognitive decline escalates during the later stages. Future research should focus on the therapeutic implications of such a model. Stopping the progress of the illness could demand to stop the succession of stages. This could be achieved not only by both halting the triggering effect of positive and negative symptoms, but also by stopping the sensitization effect on the neural pathways responsible for the development of hostility, excitement, anxiety, and depression as well as the deleterious effect on neural networks responsible for neurocognition.

Identifiants

pubmed: 32290897
doi: 10.1017/S1092852920001091
pii: S1092852920001091
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

290-298

Auteurs

Konstantinos N Fountoulakis (KN)

3rd Department of Psychiatry, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Elena Dragioti (E)

Department of Medical and Health Sciences (IMH), Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Hallunda Psychiatric Outpatient Clinic, Stockholm Psychiatric Southwest Clinic, Karolinska Huddinge University Hospital, Huddinge, Sweden.

Antonis T Theofilidis (AT)

3rd Department of Psychiatry, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Tobias Wiklund (T)

Department of Medical and Health Sciences (IMH), Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Hallunda Psychiatric Outpatient Clinic, Stockholm Psychiatric Southwest Clinic, Karolinska Huddinge University Hospital, Huddinge, Sweden.

Xenofon Atmatzidis (X)

Department of Medical and Health Sciences (IMH), Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Hallunda Psychiatric Outpatient Clinic, Stockholm Psychiatric Southwest Clinic, Karolinska Huddinge University Hospital, Huddinge, Sweden.

Ioannis Nimatoudis (I)

3rd Department of Psychiatry, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Erik Thys (E)

University Psychiatric Center, Katholieke Universiteit Leuven, Kortenberg, Belgium.

Martien Wampers (M)

University Psychiatric Center, Katholieke Universiteit Leuven, Kortenberg, Belgium.
Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium.

Luchezar Hranov (L)

University Multiprofile Hospital for Active Treatment in Neurology and Psychiatry "Sveti Naum", Sofia, Bulgaria.

Trayana Hristova (T)

University Multiprofile Hospital for Active Treatment in Neurology and Psychiatry "Sveti Naum", Sofia, Bulgaria.

Daniil Aptalidis (D)

University Multiprofile Hospital for Active Treatment in Neurology and Psychiatry "Sveti Naum", Sofia, Bulgaria.

Roumen Milev (R)

Department of Psychiatry, Queen's University, Providence Care Hospital, Kingston, Ontario, Canada.

Felicia Iftene (F)

Department of Psychiatry, Queen's University, Providence Care Hospital, Kingston, Ontario, Canada.

Filip Spaniel (F)

National Institute of Mental Health, Klecany, Czech Republic.

Pavel Knytl (P)

National Institute of Mental Health, Klecany, Czech Republic.

Petra Furstova (P)

National Institute of Mental Health, Klecany, Czech Republic.

Tiina From (T)

Department of Psychiatry, University of Turku, Turku, Finland.

Henry Karlsson (H)

Department of Psychiatry, University of Turku, Turku, Finland.

Maija Walta (M)

Department of Psychiatry, University of Turku, Turku, Finland.

Raimo K R Salokangas (RKR)

Department of Psychiatry, University of Turku, Turku, Finland.

Jean-Michel Azorin (JM)

Department of Psychiatry, Sainte Marguerite University Hospital, Marseille, France.
Timone Institute of Neuroscience, Marseille, France.

Justine Bouniard (J)

Department of Psychiatry, Sainte Marguerite University Hospital, Marseille, France.
Timone Institute of Neuroscience, Marseille, France.

Julie Montant (J)

Department of Psychiatry, Sainte Marguerite University Hospital, Marseille, France.
Timone Institute of Neuroscience, Marseille, France.

Georg Juckel (G)

Department of Psychiatry, Ruhr University Bochum, Bochum, Germany.

Ida S Haussleiter (IS)

Department of Psychiatry, Ruhr University Bochum, Bochum, Germany.

Athanasios Douzenis (A)

2nd Department of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.

Ioannis Michopoulos (I)

2nd Department of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.

Panagiotis Ferentinos (P)

2nd Department of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.

Nikolaos Smyrnis (N)

Department of Psychiatry, National and Kapodistrian University of Athens School of Medicine, Eginition Hospital, Athens, Greece.

Leonidas Mantonakis (L)

Department of Psychiatry, National and Kapodistrian University of Athens School of Medicine, Eginition Hospital, Athens, Greece.

Zsófia Nemes (Z)

Nyírő Gyula Hospital, Budapest, Hungary.

Xenia Gonda (X)

Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.

Dora Vajda (D)

Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.

Anita Juhasz (A)

Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.

Amresh Shrivastava (A)

Western University, London, Ontario, Canada.

John Waddington (J)

Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.

Maurizio Pompili (M)

Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Anna Comparelli (A)

Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Valentina Corigliano (V)

Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Elmars Rancans (E)

Department of Psychiatry and Narcology, Riga Stradins University, Riga, Latvia.

Alvydas Navickas (A)

Department of Clinic of Psychiatric, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Department of Psychosocial Rehabilitation, Vilnius Mental Health Center, Vilnius, Lithuania.
Department for Psychosis Treatment, Vilnius Mental Health Center, Vilnius, Lithuania.

Jan Hilbig (J)

Department of Clinic of Psychiatric, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Department of Psychosocial Rehabilitation, Vilnius Mental Health Center, Vilnius, Lithuania.
Department for Psychosis Treatment, Vilnius Mental Health Center, Vilnius, Lithuania.

Laurynas Bukelskis (L)

Department of Clinic of Psychiatric, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Department of Psychosocial Rehabilitation, Vilnius Mental Health Center, Vilnius, Lithuania.
Department for Psychosis Treatment, Vilnius Mental Health Center, Vilnius, Lithuania.

Lidija I Stevovic (LI)

Clinical Department of Psychiatry, Clinical Centre of Montenegro, Podgorica, Montenegro.
Department of Psychiatry, School of Medicine, University of Montenegro, Podgorica, Montenegro.
Clinical Department of Neurology, Clinical Centre of Montenegro, Podgorica, Montenegro.

Sanja Vodopic (S)

Clinical Department of Psychiatry, Clinical Centre of Montenegro, Podgorica, Montenegro.
Department of Psychiatry, School of Medicine, University of Montenegro, Podgorica, Montenegro.
Clinical Department of Neurology, Clinical Centre of Montenegro, Podgorica, Montenegro.

Oluyomi Esan (O)

Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Oluremi Oladele (O)

Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Christopher Osunbote (C)

Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Janusz K Rybakowski (JK)

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

Pawel Wojciak (P)

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

Klaudia Domowicz (K)

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

Maria L Figueira (ML)

Department of Psychiatry and Mental Health, Santa Maria University Hospital, Lisbon, Portugal.

Ludgero Linhares (L)

Department of Psychiatry and Mental Health, Santa Maria University Hospital, Lisbon, Portugal.

Joana Crawford (J)

Department of Psychiatry and Mental Health, Santa Maria University Hospital, Lisbon, Portugal.

Anca-Livia Panfil (AL)

University of Medicine and Pharmacy of Târgu Mures, Târgu Mures, Romania.

Daria Smirnova (D)

Department of Psychiatry, Samara Psychiatric Hospital, Inpatient Unit, Samara State Medical University, Samara, Russia.

Olga Izmailova (O)

Department of Psychiatry, Samara Psychiatric Hospital, Inpatient Unit, Samara State Medical University, Samara, Russia.

Dusica Lecic-Tosevski (D)

Institute of Mental Health, Belgrade, Serbia.
Serbian Academy of Sciences and Arts, Belgrade, Serbia.

Henk Temmingh (H)

Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Fleur Howells (F)

Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Julio Bobes (J)

Department of Psychiatry, University of Oviedo and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.

Maria P Garcia-Portilla (MP)

Department of Psychiatry, University of Oviedo and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.

Leticia García-Alvarez (L)

Department of Psychiatry, University of Oviedo and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.

Gamze Erzin (G)

Psychiatry Department, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Hasan Karadağ (H)

Psychiatry Department, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Avinash De Sousa (A)

Department of Psychiatry, Lokmanya Tilak Municipal Medical College, Mumbai, India.

Anuja Bendre (A)

Department of Psychiatry, Lokmanya Tilak Municipal Medical College, Mumbai, India.

Cyril Hoschl (C)

National Institute of Mental Health, Klecany, Czech Republic.

Cristina Bredicean (C)

University of Medicine and Pharmacy of Timisoara, Timisoara, Romania.

Ion Papava (I)

University of Medicine and Pharmacy of Timisoara, Timisoara, Romania.

Olivera Vukovic (O)

Institute of Mental Health, School of Medicine, University of Belgrade, Belgrade, Serbia.

Bojana Pejuskovic (B)

Department of Psychiatry, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland.

Vincent Russell (V)

Department of Psychiatry, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland.

Loukas Athanasiadis (L)

1st Department of Psychiatry, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Anastasia Konsta (A)

1st Department of Psychiatry, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Dan Stein (D)

MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Michael Berk (M)

IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Victoria, Australia.
Centre for Youth Mental Health, The Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia.
Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia.

Olivia Dean (O)

IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Victoria, Australia.
Centre for Youth Mental Health, The Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia.
Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia.

Rajiv Tandon (R)

Department of Psychiatry, University of Florida, Gainesville, Florida, USA.

Siegfried Kasper (S)

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.

Marc De Hert (M)

University Psychiatric Center, Katholieke Universiteit Leuven, Kortenberg, Belgium.
Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium.
Antwerp Health Law and Ethics Chair-AHLEC University, Antwerpen, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH